166 related articles for article (PubMed ID: 31969767)
1. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
Krznarić Ž; Markoš P; Golubić Ćepulić B; Čuković-Čavka S; Domislović V; Bojanić I; Barišić A; Kekez D
Acta Clin Croat; 2019 Sep; 58(3):529-534. PubMed ID: 31969767
[TBL] [Abstract][Full Text] [Related]
2. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
Kobayashi T; Matsuoka K; Yokoyama Y; Nakamura T; Ino T; Numata T; Shibata H; Aoki H; Matsuno Y; Hibi T
J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A
Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
[TBL] [Abstract][Full Text] [Related]
6. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis].
Sawada K; Ohnishi K; Fukunaga K; Chikano S; Egashira A; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):469-74. PubMed ID: 10726487
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
Tsujikawa T; Andoh A; Ogaẃa A; Sonoda A; Yagi Y; Hata K; Sasaki M; Saito Y; Fujiyama Y
Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
[TBL] [Abstract][Full Text] [Related]
9. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kikuyama M; Tanaka T; Kondo K; Tanaka K; Takai K
World J Gastroenterol; 2005 May; 11(20):3085-90. PubMed ID: 15918195
[TBL] [Abstract][Full Text] [Related]
10. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
[TBL] [Abstract][Full Text] [Related]
11. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.
Sawada K; Egashira A; Ohnishi K; Fukunaga K; Kusaka T; Shimoyama T
Dig Dis Sci; 2005 Apr; 50(4):767-73. PubMed ID: 15844716
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
[TBL] [Abstract][Full Text] [Related]
13. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
Sawada K; Kusugami K; Suzuki Y; Bamba T; Munakata A; Hibi T; Shimoyama T
Am J Gastroenterol; 2005 Jun; 100(6):1362-9. PubMed ID: 15929771
[TBL] [Abstract][Full Text] [Related]
14. Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
Fukunaga K; Kamikozuru K; Yokoyama Y; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kikuyama R; Kato K; Nagase K; Nakamura S; Miwa H; Matsumoto T
J Clin Apher; 2011 Dec; 26(6):326-31. PubMed ID: 22083887
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.
Umehara Y; Kudo M; Kawasaki M
World J Gastroenterol; 2008 Sep; 14(34):5316-21. PubMed ID: 18785285
[TBL] [Abstract][Full Text] [Related]
16. [Leukocytapheresis for ulcerative colitis].
Fukunaga K; Sawada K; Chikano S; Ohnishi K; Egashira A; Tanaka J; Nagase K; Satomi M; Shimoyama T
Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
[TBL] [Abstract][Full Text] [Related]
17. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis.
Sawada K; Ohnishi K; Kosaka T; Chikano S; Yokota Y; Egashira A; Izawa H; Yamamura M; Amano K; Satomi M; Shimoyama T
Ther Apher; 1997 Aug; 1(3):207-11. PubMed ID: 10225739
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
Ashida T; Kohgo Y; Munakata A; Noguchi M; Iizuka B; Endo Y; Hanai H; Yoshikawa T; Matsumoto T; Aoyama N; Matsui T; Mitsuyama K; Hibi T
Transfus Apher Sci; 2011 Apr; 44(2):113-7. PubMed ID: 21402309
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of leukocytapheresis in elderly patients with ulcerative colitis: The impact in steroid-free elderly patients.
Komoto S; Matsuoka K; Kobayashi T; Yokoyama Y; Suzuki Y; Hibi T; Miura S; Hokari R
J Gastroenterol Hepatol; 2018 Aug; 33(8):1485-1491. PubMed ID: 29406567
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
Yajima T; Takaishi H; Kanai T; Iwao Y; Watanabe M; Ishii H; Hibi T
Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
